V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003865 | 210009334 | 1.7 | 76.5 | null | 2018-11-08 | 2020-10-13 | PERTUZUMAB + TRASTUZUMAB | N | null | PERTUZUMAB + TRASTUZUMAB | 100337928 |
| 210003869 | 210009338 | 1.58 | 55.1 | Adjuvant (A) | 2017-04-05 | 2017-04-21 | null | 02 | N | LETROZOLE + PALBOCICLIB | 100691336 |
| 210003870 | 210009339 | 1.55 | 65.8 | Palliative (P) | null | 2017-03-05 | Pertuzumab (Loading) | null | N | PERTUZUMAB | 101050368 |
| 210003871 | 210009340 | 1.71 | 61.8 | null | 2018-10-02 | 2018-10-19 | Palbociclib | null | null | PACLITAXEL + TRASTUZUMAB | 101448367 |
| 210003873 | 210009342 | 1.68 | 65 | Adjuvant (A) | null | 2017-02-17 | Capecitabine | null | N | CAPECITABINE | 101698165 |
| 210003874 | 210009343 | null | 79.3 | null | 2014-10-26 | 2016-09-09 | Carboplatin + Docetaxel | 02 | null | PACLITAXEL + TRASTUZUMAB | 101181685 |
| 210003877 | 210009345 | 1.64 | 64.9 | Palliative (P) | 2016-12-06 | 2016-12-12 | FEC 100 | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100632156 |
| 210003879 | 210009346 | null | null | null | 2018-05-08 | 2018-05-10 | null | 02 | null | VINORELBINE | 100017528 |
| 210003880 | 210009347 | 1.63 | 86.85 | 03 | 2016-07-05 | 2016-07-17 | TCH (21 day Trastuzumab) Maint | 02 | N | CARBOPLATIN + DOCETAXEL | 100659335 |
| 210000002 | 210009349 | 0 | null | Neo-adjuvant (N) | 2019-08-10 | 2019-08-16 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101666120 |
| 210000022 | 210009350 | 1.65 | 75.6 | Neo-adjuvant (N) | 2022-01-30 | 2022-02-11 | Palbociclib | 02 | N | NAB-PACLITAXEL | 100160192 |
| 210000050 | 210009351 | null | null | Adjuvant (A) | 2019-09-09 | 2019-09-26 | ABEMACICLIB + FULVESTRANT | N | N | TCH | 100148879 |
| 210000326 | 210009357 | 0 | 56.6 | null | 2019-10-02 | 2019-12-04 | FEC 100 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101735304 |
| 210000406 | 210009359 | 1.54 | null | Neo-adjuvant (N) | null | 2019-06-20 | null | 02 | N | CARBOPLATIN + GEMCITABINE | 101185927 |
| 210000413 | 210009360 | 1.48 | 83.2 | Adjuvant (A) | null | 2018-12-07 | Eribulin | 02 | N | ERIBULIN | 101261105 |
| 210000562 | 210009361 | 1.6 | 68.1 | Adjuvant (A) | null | 2021-08-05 | null | 02 | N | CARBOPLATIN + DOCETAXEL | 101698914 |
| 210000730 | 210009362 | 1.6 | 69.4 | null | 2019-11-20 | 2019-11-30 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 100737972 |
| 210000905 | 210009368 | null | 76.9 | null | 2017-12-29 | 2018-03-26 | Trial Unspecified | null | null | LETROZOLE + PALBOCICLIB | 101742852 |
| 210000921 | 210009369 | 1.72 | 66.7 | Neo-adjuvant (N) | 2015-10-29 | 2019-06-05 | Capecitabine 35days + RT | null | N | CAPECITABINE | 101314024 |
| 210001086 | 210009371 | null | 57 | Palliative (P) | 2019-06-26 | 2019-07-05 | NAB PACLITAXEL | 02 | N | FEC | 101663547 |
| 210001109 | 210009372 | null | null | null | null | 2017-12-24 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100904517 |
| 210001126 | 210009375 | null | 109.3 | Neo-adjuvant (N) | 2018-12-08 | 2018-12-31 | null | 02 | N | ATEZOLIZUMAB + NAB-PACLITAXEL | 101674658 |
| 210001235 | 210009378 | 1.58 | 74.3 | Adjuvant (A) | null | 2019-12-10 | EC | N | N | EC | 101675386 |
| 210001255 | 210009380 | 1.54 | 0 | Adjuvant (A) | 2020-12-18 | 2020-12-24 | Eribulin | 02 | N | ERIBULIN | 100481126 |
| 210001286 | 210009381 | 1.66 | 71 | null | null | 2020-06-27 | Pertuzumab (Loading) | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100797849 |
| 210001373 | 210009382 | 1.67 | 67.8 | Neo-adjuvant (N) | 2019-04-01 | 2019-04-11 | Cyclophosphamide+Doce+Tras Main | 02 | N | LETROZOLE + PALBOCICLIB | 101373807 |
| 210001443 | 210009384 | 1.63 | 77.7 | Palliative (P) | null | 2018-10-27 | FEC | N | N | ROSCO TRIAL | 100966119 |
| 210001592 | 210009389 | 1.62 | 110.3 | null | 2016-08-24 | 2016-11-06 | Neratinib | 02 | null | NERATINIB | 101801550 |
| 210001640 | 210009393 | 1.55 | 67.9 | Palliative (P) | 2019-11-17 | 2020-04-15 | Eribulin | 02 | N | ERIBULIN | 101143276 |
| 210001782 | 210009396 | null | null | Palliative (P) | 2020-02-02 | 2020-03-03 | TCH (21 day Trastuzumab) Maint | 02 | N | TCH | 100854706 |
| 210001833 | 210009398 | 1.57 | 69.8 | null | null | 2018-07-28 | Paclitaxel+Trastuzumab wkly Maint | null | null | PACLITAXEL + TRASTUZUMAB | 101799390 |
| 210001844 | 210009399 | 1.62 | 62.7 | null | 2020-10-15 | 2020-12-30 | null | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100737108 |
| 210001895 | 210009401 | 1.54 | 0 | Palliative (P) | null | 2019-10-10 | Capecitabine | null | N | ROSCO TRIAL | 101237820 |
| 210001953 | 210009402 | null | null | null | null | 2018-01-07 | DOCETAXEL + TRASTUZUMAB | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101710755 |
| 210001961 | 210009403 | null | null | Neo-adjuvant (N) | null | 2020-06-13 | Carboplatin AUC 6 - 10 | null | N | CARBOPLATIN | 101469850 |
| 210001963 | 210009404 | 1.62 | 77.7 | Adjuvant (A) | 2020-01-21 | 2020-02-09 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101232145 |
| 210002016 | 210009406 | 1.68 | 95.6 | null | 2016-12-01 | 2016-12-31 | FEC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101019512 |
| 210002107 | 210009410 | null | null | null | 2017-11-24 | 2017-11-24 | null | 02 | null | LETROZOLE + PALBOCICLIB | 101536240 |
| 210002168 | 210009415 | 1.7 | 46.2 | Adjuvant (A) | null | 2019-07-03 | null | null | N | POMALIDOMIDE | 101002461 |
| 210002229 | 210009416 | 1.59 | 64 | null | null | 2019-10-21 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101584469 |
| 210002412 | 210009421 | 1.61 | 117.25 | Neo-adjuvant (N) | null | 2017-08-05 | EC | 02 | N | EC | 100071313 |
| 210002431 | 210009422 | 1.66 | 92.1 | Neo-adjuvant (N) | 2020-08-13 | 2020-09-04 | ABEMACICLIB + FULVESTRANT | N | N | SACITUZUMAB GOVITECAN | 100024558 |
| 210002467 | 210009425 | 1.63 | 69.4 | Adjuvant (A) | 2020-03-05 | 2020-03-13 | EC | 02 | N | EC | 100194392 |
| 210002644 | 210009429 | null | null | null | 2019-05-03 | 2019-07-27 | Olaparib | null | null | CARBOPLATIN + DOCETAXEL | 101704040 |
| 210002826 | 210009432 | 1.58 | 94.1 | Palliative (P) | 2019-06-19 | 2019-07-18 | null | N | N | PALBOCICLIB | 100004928 |
| 210002942 | 210009434 | 1.75 | null | Neo-adjuvant (N) | null | 2018-11-20 | Capecitabine | N | N | CAPECITABINE | 101053988 |
| 210003249 | 210009438 | 1.66 | 56.35 | null | 2018-10-27 | 2018-11-13 | Letrozole + Palbociclib | 02 | null | PACLITAXEL + TRASTUZUMAB | 100715933 |
| 210003283 | 210009440 | null | 88.9 | null | 2022-03-01 | 2022-03-16 | Eribulin | null | null | ERIBULIN | 101017890 |
| 210003324 | 210009441 | 1.58 | 64.2 | null | 2021-12-14 | 2021-12-28 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100837867 |
| 210003439 | 210009443 | null | null | null | 2017-07-31 | 2017-10-03 | GemCarbo Days 1+8 | null | null | CARBOPLATIN + DOCETAXEL | 100457558 |